AETHLON MEDICAL INC (AEMD) Stock Fundamental Analysis

NASDAQ:AEMD • US00808Y6041

1.87 USD
-0.14 (-6.97%)
At close: Mar 2, 2026
1.8738 USD
+0 (+0.2%)
After Hours: 3/2/2026, 8:01:26 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

Overall AEMD gets a fundamental rating of 2 out of 10. We evaluated AEMD against 184 industry peers in the Health Care Equipment & Supplies industry. No worries on liquidiy or solvency for AEMD as it has an excellent financial health rating, but there are worries on the profitability. AEMD has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year AEMD has reported negative net income.
  • AEMD had a negative operating cash flow in the past year.
  • AEMD had negative earnings in each of the past 5 years.
  • In the past 5 years AEMD always reported negative operating cash flow.
AEMD Yearly Net Income VS EBIT VS OCF VS FCFAEMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -2M -4M -6M -8M -10M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -143.01%, AEMD is doing worse than 85.33% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -171.64%, AEMD is doing worse than 70.65% of the companies in the same industry.
Industry RankSector Rank
ROA -143.01%
ROE -171.64%
ROIC N/A
ROA(3y)-131.15%
ROA(5y)-104.21%
ROE(3y)-181.8%
ROE(5y)-137.98%
ROIC(3y)N/A
ROIC(5y)N/A
AEMD Yearly ROA, ROE, ROICAEMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -200 -400 -600 -800 -1K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for AEMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AEMD Yearly Profit, Operating, Gross MarginsAEMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1K -2K -3K

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. Health

2.1 Basic Checks

  • Compared to 1 year ago, AEMD has more shares outstanding
  • Compared to 5 years ago, AEMD has more shares outstanding
  • AEMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AEMD Yearly Shares OutstandingAEMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50K 100K 150K 200K 250K
AEMD Yearly Total Debt VS Total AssetsAEMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

2.2 Solvency

  • AEMD has an Altman-Z score of -31.40. This is a bad value and indicates that AEMD is not financially healthy and even has some risk of bankruptcy.
  • With a Altman-Z score value of -31.40, AEMD is not doing good in the industry: 90.22% of the companies in the same industry are doing better.
  • AEMD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -31.4
ROIC/WACCN/A
WACCN/A
AEMD Yearly LT Debt VS Equity VS FCFAEMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5M -5M 10M -10M 15M

2.3 Liquidity

  • A Current Ratio of 5.68 indicates that AEMD has no problem at all paying its short term obligations.
  • AEMD has a Current ratio of 5.68. This is amongst the best in the industry. AEMD outperforms 80.98% of its industry peers.
  • A Quick Ratio of 5.68 indicates that AEMD has no problem at all paying its short term obligations.
  • AEMD has a better Quick ratio (5.68) than 84.78% of its industry peers.
Industry RankSector Rank
Current Ratio 5.68
Quick Ratio 5.68
AEMD Yearly Current Assets VS Current LiabilitesAEMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. Growth

3.1 Past

  • AEMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.32%, which is quite impressive.
EPS 1Y (TTM)25.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.44%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 14.58% on average over the next years. This is quite good.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y91.47%
EPS Next 2Y40.36%
EPS Next 3Y25.2%
EPS Next 5Y14.58%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AEMD Yearly Revenue VS EstimatesAEMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2030 2031 2032 2033 10M 20M 30M 40M
AEMD Yearly EPS VS EstimatesAEMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 -5K -10K -15K -20K

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for AEMD. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for AEMD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AEMD Price Earnings VS Forward Price EarningsAEMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AEMD Per share dataAEMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -20 -40 -60 -80

4.3 Compensation for Growth

  • AEMD's earnings are expected to grow with 25.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.36%
EPS Next 3Y25.2%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • AEMD does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

AETHLON MEDICAL INC

NASDAQ:AEMD (3/2/2026, 8:01:26 PM)

After market: 1.8738 +0 (+0.2%)

1.87

-0.14 (-6.97%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-12
Earnings (Next)06-24
Inst Owners3.84%
Inst Owner Change-96.82%
Ins Owners0.08%
Ins Owner Change-0.72%
Market Cap1.81M
Revenue(TTM)N/A
Net Income(TTM)-11.52M
Analysts45.71
Price Target11.73 (527.27%)
Short Float %5.36%
Short Ratio0.66
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.33%
Min EPS beat(2)-0.09%
Max EPS beat(2)0.75%
EPS beat(4)2
Avg EPS beat(4)-167.47%
Min EPS beat(4)-673.64%
Max EPS beat(4)3.1%
EPS beat(8)4
Avg EPS beat(8)-76.07%
EPS beat(12)6
Avg EPS beat(12)-48.68%
EPS beat(16)8
Avg EPS beat(16)-42.5%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-7.07%
PT rev (3m)-7.07%
EPS NQ rev (1m)-12.85%
EPS NQ rev (3m)-12.85%
EPS NY rev (1m)0%
EPS NY rev (3m)19.41%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.27
P/tB 0.27
EV/EBITDA N/A
EPS(TTM)-94.39
EYN/A
EPS(NY)-3.99
Fwd EYN/A
FCF(TTM)-7.13
FCFYN/A
OCF(TTM)-7.13
OCFYN/A
SpS0
BVpS6.92
TBVpS6.92
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -143.01%
ROE -171.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-131.15%
ROA(5y)-104.21%
ROE(3y)-181.8%
ROE(5y)-137.98%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 0.15%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.68
Quick Ratio 5.68
Altman-Z -31.4
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)153.85%
Cap/Depr(5y)180.64%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)25.32%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.44%
EPS Next Y91.47%
EPS Next 2Y40.36%
EPS Next 3Y25.2%
EPS Next 5Y14.58%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y25.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y35.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y34.18%
OCF growth 3YN/A
OCF growth 5YN/A

AETHLON MEDICAL INC / AEMD FAQ

Can you provide the ChartMill fundamental rating for AETHLON MEDICAL INC?

ChartMill assigns a fundamental rating of 2 / 10 to AEMD.


Can you provide the valuation status for AETHLON MEDICAL INC?

ChartMill assigns a valuation rating of 1 / 10 to AETHLON MEDICAL INC (AEMD). This can be considered as Overvalued.


Can you provide the profitability details for AETHLON MEDICAL INC?

AETHLON MEDICAL INC (AEMD) has a profitability rating of 0 / 10.